ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 39 filers reported holding ELEDON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $154,454 | -17.4% | 67,743 | 0.0% | 0.01% | -12.5% |
| Q3 2022 | $186,971 | +29.7% | 67,743 | +14.7% | 0.02% | +60.0% |
| Q2 2022 | $144,119 | -67.9% | 59,065 | -48.2% | 0.01% | -70.6% |
| Q1 2022 | $449,192 | -10.7% | 114,008 | 0.0% | 0.03% | +6.2% |
| Q4 2021 | $502,775 | -28.6% | 114,008 | 0.0% | 0.03% | -34.7% |
| Q3 2021 | $704,569 | – | 114,008 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 1,339,793 | $10,598,000 | 0.89% |
| CM Management, LLC | 75,000 | $593,000 | 0.43% |
| Cormorant Asset Management, LP | 1,415,500 | $11,197,000 | 0.38% |
| BVF INC/IL | 1,113,435 | $8,807,000 | 0.33% |
| Ikarian Capital, LLC | 350,000 | $2,769,000 | 0.22% |
| Woodline Partners LP | 857,445 | $6,782,000 | 0.13% |
| INGALLS & SNYDER LLC | 51,149 | $405,000 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 853,208 | $6,749,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 40,052 | $317,000 | 0.01% |
| Point72 Asset Management, L.P. | 188,690 | $1,493,000 | 0.01% |